Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4430-4434

  Credito, Kim L ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN PHOSPHATE; DALFOPRISTIN PLUS QUINUPRISTIN; IMIPENEM; LINEZOLID; MACROCYCLIC COMPOUND; METRONIDAZOLE; NEW DRUG; OPT 80; TEICOPLANIN; TIACUMICIN B; UNCLASSIFIED DRUG; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; CLOSTRIDIUM; GLYCOSIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 7244250115     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4430-4434.2004     Document Type: Article

References (18)

1. Ackermann, G., B. Löffler, D. Adler, and A. C. Rodloff. 2004. In vitro activity of OPT-80 against Clostridium difficile. Antimicrob. Agents Chemother. 48:2280-2282.
2. American Society of Health-System Pharmacists. 1998. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease. Am. J. Health Syst. Pharm. 55:1407-1411.
3. Bartlett, J. G. 1992. Antibiotic-associated diarrhea. Clin. Infect. Dis. 15:573-581.
4. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). 1995. Morb. Mortal. Wkly. Rep. Recomm. Rep. 44:1-13.
5. Ednie, L. M., A. Rattan, M. R. Jacobs, and P. C. Appelbaum. 2003. Antianaerobic activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents. Antimicrob. Agents Chemother. 47:1143-1147.
6. Fekety, R., et al. 1997. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am. J. Gastroenterol. 92:739-750.
7. Fekety, R., and A. B. Shah. 1993. Diagnosis and treatment of Clostridium difficile colitis. JAMA 269:71-75.
8. Guerrant, R. L., J. M. Hughes, N. L. Lima, and J. Crane. 1990. Diarrhea in developed and developing countries: magnitude, special settings and etiologies. Rev. Infect. Dis. 12(Suppl. 1):S41-S50.
9. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Co., Belmont, Calif.
10. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994, Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
11. McFarland, L. V. 1995, Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am. J. Infect. Control 23:295-305.
12. Miller, M. A., M. Hyland, M. Ofner-Agostini, M. Gourdeau, and M. Ishak. 2002. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect. Control Hosp. Epidemiol. 23:137-140.
13. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed.; approved standard. NCCLS publication no. M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Swanson, R. N., D. J. Hardy, N. L. Shipkowitz, C. W. Hanson, N. C. Ramer, P. B. Fernandes, and J. J. Clement. 1991. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrob. Agents Chemother. 35:1108-1111.
15. Theriault, R. J., J. P. Karwowski, M. Jackson, R. L. Girolami, G. N. Sunga, C. M. Vojtko, and L. J. Coen. 1987. Tiacumicins, a novel complex of 18-membered macrolide antibiotics. J. Antibiot. 40:567-574,
16. Wilcox, M. H. 1996. Cleaning up Clostridium difficile colitis. Lancet 348:767-768.
17. Wistrom, J., S. R. Norrby, E. B. Myhre, S. Eriksson, G. Granstrom, L. Lagergren, G. Englund, C. E. Nord, and B. Svenungsson. 2001. Frequency of antibiotic-associated diarrhea in 2,462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemother. 47:43-50.
18. Yassin, S. F., T. M. Young-Fadok, N. N. Zein, and D. S. Pardi. 2001. Clostridium difficile-associated diarrhea and colitis. Mayo Clin. Proc. 76:725-730.